Cryptomarket drug sales have surged dramatically over the past year, with dark web listings jumping from 27,630 to 39,288 between October 2024 and September 2025. This represents a 42% increase in available drugs sold through anonymous online marketplaces, according to new data from Drug Trends monitoring research.

Cannabis dominated cryptomarket drug sales throughout the monitoring period, comprising 25.8% of all listings. Benzodiazepines followed at 8.0%, with MDMA at 7.9% and opioids (excluding heroin) at 7.4%. However, the fastest-growing category involved psychotropic medicines including pregabalin, gabapentin and quetiapine, which increased from 1.8% to 2.8% of market share.

Dark Web Market Landscape Shifts

Researchers monitored 15 cryptomarkets from October 2024 to September 2025, with 10 remaining active at the reporting period’s end. Three markets reached over 10,000 listings during snapshots: Archetyp, Drughub and Abacus. By September 2025, Drughub, Dark Matter, Torzon and Nexus emerged as the largest accessible platforms for cryptomarket drug sales.

The data reveals cryptomarket drug sales growing at an estimated 2.8% monthly rate, though this increase lacks statistical significance. Cannabis listings, whilst remaining dominant, showed a slight decrease from 26.2% to 24.9% of market share during the monitoring period.

Cocaine accounted for 7.0% of cryptomarket drug sales, with performance and image-enhancing drugs plus weight loss products at 6.0%. Methamphetamine and illicit amphetamines comprised 5.9% of listings. The diversification of available substances demonstrates how cryptomarkets facilitate access to a broad spectrum of drugs through encrypted, anonymous transactions.

Public Health Implications

The Drug Trends research, conducted continuously since February 2014, provides critical intelligence on evolving cryptomarket drug sales patterns. An accompanying interactive data visualisation allows public health officials, researchers and policymakers to examine trends across the entire monitoring period.

The surge in psychotropic medicine availability raises particular concerns. These prescription medications, including anticonvulsants and antipsychotics, carry significant risks when obtained outside medical supervision. Their increasing presence in cryptomarket drug sales suggests growing demand for substances that may be difficult to access through legitimate channels.

The data underscores how cryptomarkets continue evolving as drug distribution mechanisms. Despite law enforcement efforts and marketplace closures, the overall volume of cryptomarket drug sales demonstrates resilience. New platforms emerge to replace shuttered markets, maintaining continuous availability for buyers seeking anonymous transactions.

Understanding these trends enables more effective prevention strategies and helps communities recognise emerging threats before they escalate into widespread public health crises.

Source: UNSW